Confidentiality

Algorithme Pharma follows very rigorous personal information protection and safety policies and practices in accordance with the HIPAA (Health Insurance Portability and Accountability Act).

Your name and address will be kept confidential.
You will only be referred to by a code number and your initials.

Protection and Safety Policies and Practices

Algorithme Pharma pays particular attention to personal information to ensure it is kept completely confidential. Access to this information is granted only to authorized Algorithme Pharma personnel, sponsors and regulatory agencies. 

The Consent

Most of the information we collect is gathered when you inquire about participating in one of our clinical trials. During this process, we ask only for information needed to process your request, and that will help us present studies that may interest. It is important for us to obtain your consent to collect, use and communicate your personal information. Your consent must be informed and it must be given for a specific purpose. Sometimes, you may be asked to give an explicit consent. There are different types of explicit consent, like checking a box when you agree to receive communications, or signing an application form to show you accept its conditions of use and disclosure.

Documents

The results of the study will be passed on to appropriate authorities, such as the study sponsor, and potentially state or federal regulatory agencies who approve product usage in the general public. All essential documents and records will be maintained at Algorithme Pharma for a period of at least 25 years.

Your name and address will be kept confidential. You will only be referred to by a code number and your initials.

 

Your name and address will be kept confidential. You will only be referred to by a code number and your initials. Representatives of the sponsor, institutional review board (IRB - also known as ethics committee), or local or foreign regulatory authorities (such as Health Canada, the Food and Drug Administration and the European Medicines Agency) may wish to examine your records to verify the information collected during the screening tests and throughout the study. They all subscribe to a strict confidentiality policy. Your identity will remain confidential if the results of this study are published.